Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Gematek

Gematek?uq=gJQ7UQwH
2004 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Manufacturer of infusion chemicals intended to produce medicinal products. The company's spectrum of infusion chemicals include sodium chloride and glucose of purity grade A, packed in plastic bottles with a capacity of 250 and 500 milliliters combining the machine process of blowing, filling and sealing, enabling pharmaceutical companies to get the best quality packaged infusion chemicals.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Industrial Chemicals
Parent Company
B. Braun Melsungen
Primary Office
  • Ul. Seaside, d. 4
  • Lit. A pom. 2-N
  • Saint Petersburg, 192076
  • Russia

+7 8 (000) 000-00-00

Gematek Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Gematek‘s full profile, request access.

Request full access to PitchBook

Gematek Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Gematek‘s full profile, request access.

Request full access to PitchBook

Gematek Executive Team (1)

Name Title Board
Seat
Contact
Info
Maxim Zakharchenko Chief Executive Officer, Chief Financial Officer and General Director